Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: November 28, 2022

Dr Reddys Labs Ltd Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for DR REDDYS LABS LTD, and what generic and branded alternatives to DR REDDYS LABS LTD drugs are available?

DR REDDYS LABS LTD has eighty-four approved drugs.

There are seventeen tentative approvals on DR REDDYS LABS LTD drugs.

Summary for Dr Reddys Labs Ltd

US Patents:	0
Tradenames:	68
Ingredients:	63
NDAs:	84

Drugs and US Patents for Dr Reddys Labs Ltd

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dr Reddys Labs Ltd	MONTELUKAST SODIUM	montelukast sodium	GRANULE;ORAL	202906-001	Sep 17, 2012	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Dr Reddys Labs Ltd	GLYCOPYRROLATE	glycopyrrolate	TABLET;ORAL	040847-002	Mar 21, 2008	AA	RX	No	No		See Plans and Pricing				See Plans and Pricing
Dr Reddys Labs Ltd	LANSOPRAZOLE	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	202194-001	May 18, 2012		OTC	No	No		See Plans and Pricing				See Plans and Pricing
Dr Reddys Labs Ltd	FAMOTIDINE	famotidine	TABLET;ORAL	077367-001	Sep 25, 2006		OTC	No	No		See Plans and Pricing				See Plans and Pricing
Dr Reddys Labs Ltd	MINOCYCLINE HYDROCHLORIDE	minocycline hydrochloride	TABLET;ORAL	065436-001	Dec 26, 2007	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Dr Reddys Labs Ltd	IBUPROFEN AND DIPHENHYDRAMINE CITRATE	diphenhydramine citrate; ibuprofen	TABLET;ORAL	090619-001	Jul 8, 2009		OTC	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for DR REDDYS LABS LTD drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Medtronic

McKesson

Dow

McKinsey

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.